Management
-
Rainer Lichtenberger, Ph.D. MBA
CEOMore than 30 years management in life science Industry, EVP Merckle/ratiopharm group for BD; Since 16 years CEO/COO experience in several SME, raised € 80 Mn venture funds.
Read more -
Christian Wallasch, Ph.D.
COOSeasoned executive management member (COO, CEO) in biopharmaceuticals SME, as Axxima and U3, as well as public companies like Intercell/Valneva. Expert in kinase inhibitors, vaccines development, project management and execution.
Read more -
Olaf Althaus
CFO20 years of Biotech industry, active as entrepreneur, manager, deal maker, Co-founder, CEO and CFO of CellMed AG, MD of AEterna Zentaris, 10 years Private Equity & M&A-Advisory
Read more -
Stephan Stenglein, M.D.
CMOPhysician trained in Clinical and Molecular Virology with 20 years of accomplishments in pharma, medical device and vaccine development. Previous global management positions with Novartis and AstraZeneca.
Read more -
Prof. Oliver Planz, Ph.D.
CSOUniversität D-Tübingen,Co-inventor of the technology, expert in antiviral research und translational preclinical R&D up to clinical studies. Advises the WHO on antiviral strategies against influenza.
Read more -
Björn Cochlovius, Ph.D., Assoc. Prof.
VP Business Development20 years leadership positions in SMEs (Head R&D Affitech, CEO OnTarget) and big pharma (Roche, Otsuka, Abbvie). Working experiences in Europe and Asia. Background in R&D, Business Development, M&A, Financing
Read more
- 1